CompoAtlas

Anaca 3 stress sommeil

Food supplement declared in France, declaration No 2016-7-910

Anaca 3 stress sommeil is a food supplement declared in France. Status: retiré du marché le 30 September 2018. 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
NUTRAVALIA
Status
Retiré du marché le 30 September 2018
Form
Gélule
Daily dose
2 gélules
Directions for use
Prendre 2 gélules avant le coucher, à avaler avec un verre d'eau.
Not recommended for (according to the manufacturer)
Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Sous traitement antihypertenseur
Objectives stated by the manufacturer (these are not authorised claims)
Sommeil

Declaration 275221, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Passiflora incarnata L.Parties aériennesExtrait sec hydroalcoolique375 mg
Citrus aurantium L.FeuillePoudre (de plantes séchées ou broyées)250 mg
Melissa officinalis L.FeuilleExtrait sec aqueux80 mg
Tanacetum parthenium (L.) Sch.Bip.Parties aériennesPoudre (de plantes séchées ou broyées)50 mg

Other active ingredients

NamePer day
Mélatoninenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Oxyde de magnésiumMagnésium250 mg300 mg
Sélénite de sodiumSélénium255 µg50 µg
Chlorhydrate de thiamineVitamine B1 (thiamine)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011

Additives

E470b, E551

Other ingredients

gélatine

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Enter to analyse, Shift+Enter for a new line